Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Global Heparin Market 2015-2019 - Key Vendors are Aspen, Leo Pharma, Pfizer & Sanofi-Aventis | ||
By: PR Newswire Association LLC. - 30 Jun 2015 | Back to overview list |
|
DUBLIN, June 24, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/f9k5fz/global_heparin) has announced the addition of the "Global Heparin Market 2015-2019" report to their offering. Heparin is an anticoagulant or blood thinner produced by basophils and mast cells. Though it has no effect on already formed clots, it enables the body's natural clot lysis mechanisms to function and dissolve clots. A porcine intestine or bovine lungs extract of heparin is used pharmaceutically in conditions such as DVT, pulmonary embolism, acute coronary syndrome, and atrial fibrillation to prevent clots. It is also used during surgeries to prevent clot formation. The anti-inflammatory activity of heparin is a recent discovery. Heparin exhibits this trait through the neutralization of cationic mediators, inhibition of adhesion molecules, and the inhibition of heparanase, all of which are involved in leukocyte recruitment into tissues. Further studies are being conducted to exploit the use of heparin as an anti-inflammatory agent.
Key Vendors
Other Prominent Vendors
Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/f9k5fz/global_heparin Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net SOURCE Research and Markets |
||
|
||
Copyright 2015 PR Newswire Association LLC. | Back to overview list |